Omeprazole Arrow Conseil

Omeprazole, the active ingredient in Omeprazole Arrow Conseil, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults and children.

GNH USA supplies Omeprazole Arrow Conseil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Arrow Conseil is a proton pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer formation in patients requiring long‑term NSAID therapy.

Omeprazole Arrow Conseil may cause a range of adverse reactions.

Common Side Effects: - Headache: mild, transient headache reported in many patients. - Diarrhea: loose stools occurring during early treatment. - Abdominal pain: mild discomfort or cramping. - Nausea: occasional feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Acute interstitial nephritis: sudden kidney inflammation. - Hypomagnesemia: low serum magnesium with prolonged use. - Stevens‑Johnson syndrome: rare severe skin reaction. - Fracture risk: increased incidence of hip, wrist or spine fractures with long‑term therapy. - Liver enzyme elevation: raised ALT/AST levels indicating hepatic stress.

When using Omeprazole Arrow Conseil, consider the following precautions. - Assess renal function: adjust use in patients with severe kidney impairment. - Review hepatic status: use cautiously in moderate to severe liver disease. - Monitor long‑term use: evaluate need for continued therapy after 12 months. - Pregnancy and lactation: weigh benefits against potential risks; consult a prescriber. - Drug interactions: check for concomitant medications that may alter acid‑dependent absorption. - Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture.

Omeprazole Arrow Conseil can interact with several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, compromising HIV treatment. - Dasatinib: lowered plasma concentrations, reducing anticancer efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring more frequent monitoring. - Phenytoin: decreased serum levels, possibly reducing seizure control. - Digoxin: elevated serum concentrations, raising toxicity risk.